Korean Skincare Brand Dr.Althea Launches 345 Relief Serum Exclusively at Sephora UK
LONDON, July 20, 2026 /PRNewswire/ -- Following the global success of its bestselling 345 Relief Cream, which has surpassed 30 million...
Read moreDetails
Press Releases – Lifestyle
Trinasolar and Al-Raebi Sign Memorandum of Understanding to Explore 1.5 GW Solar Project Pipeline in Yemen
Trinasolar's latest TOPCon 3.0 modules to support potential large-scale solar projects in Yemen between 2026 and 2029SANA'A, Yemen, July 20,...
Read moreDetailsLundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with...
Read moreDetailsSearch initiative launched for missing Flying Tigers pilots 85 years after landmark mission
NANJING, China, July 20, 2026 /PRNewswire/ -- A report from JiangsuNow. A commemorative event marking the 85th anniversary of the...
Read moreDetailsShare buybacks in Ericsson during the period July 13 – July 17, 2026
STOCKHOLM, July 20, 2026 /PRNewswire/ -- During the period July 13 - July 17, 2026, Telefonaktiebolaget LM Ericsson (publ) ("Ericsson") (LEI...
Read moreDetailsShinsung Materials Leads Clean Beauty with High-Performance Cosmetic Ingredients, Differentiated Processes and Eco-Friendly Practices
Strengthens global competitiveness by producing widely used water-soluble UV filters, naturally derived oil thickeners and natural preservative systemsSEOUL, South Korea,...
Read moreDetails
Short Documentary “South China Sea: Our Story” Highlights Regional Peace and Cooperation
BEIJING, July 20, 2026 /PRNewswire/ -- As the waters of the South China Sea are increasingly stirred by geopolitical rivalry,...
Read moreDetails
Fostering new opportunities in the Greater Bay Area and Asia’s Pharmaceutical Industry
SHANGHAI, July 20, 2026 /PRNewswire/ -- Following the landmark success of CPHI & PMEC China in June 2026, which welcomed...
Read moreDetailsAkeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC
HONG KONG, July 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient...
Read moreDetailsSaber Astronautics releases new spacecraft constellation control and automation software SABER COMMANDER
SYDNEY, July 20, 2026 /PRNewswire/ -- Saber Astronautics today announced the release of Saber Commander, its new spacecraft and constellation operations...
Read moreDetails